Ledger.Open graph →
SEC Form D · filed April 2, 2014

SynerGene Therapeutics, Inc

Offering
$3.0M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
POTOMAC, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Samuel Chang · Potomac, MDDirectorMaria M. Ruiz · Potomac, MDExecJames Hsu · Potomac, MDDirectorDonald G. Nikols · Newport Beach, CADirectorJames J. Ratigan · Bristol, PADirectorDartanian V. Sanders · Sheridan, WYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗